Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study.

Maria Tsachiridi, George Galyfos, Alexandros Andreou, Argiri Sianou, Fragiska Sigala, George Zografos, Konstantinos Filis
Author Information
  1. Maria Tsachiridi: First Department of Propedeutic Surgery, Hippocration General Hospital, National Kapodistrian University of Athens, Athens, Greece. ORCID
  2. George Galyfos: First Department of Propedeutic Surgery, Hippocration General Hospital, National Kapodistrian University of Athens, Athens, Greece. ORCID
  3. Alexandros Andreou: Department of General Surgery, York Hospital, York Teaching Hospital NHS Trust, York, United Kingdom. ORCID
  4. Argiri Sianou: Department of Microbiology, Areteion University Hospital, Athens, Greece. ORCID
  5. Fragiska Sigala: First Department of Propedeutic Surgery, Hippocration General Hospital, National Kapodistrian University of Athens, Athens, Greece. ORCID
  6. George Zografos: First Department of Propedeutic Surgery, Hippocration General Hospital, National Kapodistrian University of Athens, Athens, Greece. ORCID
  7. Konstantinos Filis: First Department of Propedeutic Surgery, Hippocration General Hospital, National Kapodistrian University of Athens, Athens, Greece. ORCID

Abstract

PURPOSE: The use of platelet-rich plasma (PRP) for the treatment of nonhealing ulcers is a relatively new technique. Although it seems to result in a satisfying level of healing and low complication rates, data regarding its effectiveness remain sparse. This study aims to evaluate the potential therapeutic effects of PRP on chronic nonhealing ulcers.
MATERIALS AND METHODS: This was a prospectively designed study comparing outcomes between patients treated with PRP (Group A, n=15) and patients treated conventionally (Group B, n=12) for different types of nonhealing ulcers. In Group A, PRP was produced from the patients' own peripheral blood samples and was applied on the ulcer once every week. In Group B, patients were treated conventionally, without applying PRP. The total treatment period was 5 weeks.
RESULTS: Both groups were similar regarding age, sex, comorbidities, and time of treatment. In Group A, patients showed a nonsignificant reduction of 4.5 mm in ulcer area (P=0.190) and a reduction of more than 1 mm in depth (P=0.0006), while Group B showed an increase of 108±80.5 mm in ulcer area after 5 weeks (P=0.016). The healing rate (HR) in Group A was stable and positive throughout the treatment period, while HR in Group B was initially negative but became positive after the 3rd week.
CONCLUSION: PRP application once a week promotes the healing of chronic ulcers. It improves the ulcer's depth and HR, although its effect on ulcer area seems to be nonsignificant. However, larger comparative series are still needed to confirm these findings.

Keywords

References

  1. Bull Mem Acad R Med Belg. 2001;156(3-4):175-84; discussion 185 [PMID: 11789398]
  2. Facial Plast Surg. 2002 Feb;18(1):27-33 [PMID: 11823930]
  3. J Craniofac Surg. 2005 Nov;16(6):1043-54 [PMID: 16327552]
  4. Trends Biotechnol. 2006 May;24(5):227-34 [PMID: 16540193]
  5. Ophthalmic Plast Reconstr Surg. 2006 Mar-Apr;22(2):102-4 [PMID: 16550052]
  6. J Extra Corpor Technol. 2006 Jun;38(2):174-87 [PMID: 16921694]
  7. J Am Podiatr Med Assoc. 2006 Nov-Dec;96(6):482-8 [PMID: 17114601]
  8. J Orthop Trauma. 2008 Jul;22(6):432-8 [PMID: 18594311]
  9. World J Surg. 2009 Aug;33(8):1764-9 [PMID: 19424751]
  10. J Int Med Res. 2009 Sep-Oct;37(5):1528-42 [PMID: 19930861]
  11. Growth Factors. 2010 Apr;28(2):111-6 [PMID: 20001406]
  12. Int Wound J. 2011 Jun;8(3):307-12 [PMID: 21470370]
  13. J Control Release. 2012 Jan 10;157(1):29-38 [PMID: 21763737]
  14. Adv Skin Wound Care. 2011 Aug;24(8):357-68 [PMID: 21768787]
  15. Decubitus. 1990 Nov;3(4):14-7 [PMID: 2242232]
  16. Immun Ageing. 2013 Jun 13;10(1):23 [PMID: 23763951]
  17. Stem Cell Rev. 2014 Jun;10(3):417-28 [PMID: 24500853]
  18. Biol Res Nurs. 2015 Mar;17(2):152-8 [PMID: 24848975]
  19. Ann Biomed Eng. 2015 Feb;43(2):297-305 [PMID: 25480479]
  20. Vascular. 2015 Dec;23(6):580-5 [PMID: 25492574]
  21. Wound Repair Regen. 2015 Sep;23(5):638-43 [PMID: 26019054]
  22. Cochrane Database Syst Rev. 2016 May 25;(5):CD006899 [PMID: 27223580]
  23. HSS J. 2017 Feb;13(1):75-80 [PMID: 28167878]
  24. Clin Nurs Res. 2018 Jul;27(6):643-659 [PMID: 28447852]

Word Cloud

Created with Highcharts 10.0.0GroupPRPtreatmentulcerspatientsBulcer5nonhealinghealingtreatedweekmmareaP=0HRplasmaseemsregardingstudychronicconventionallyperiodweeksshowednonsignificantreductiondepthpositivePURPOSE:useplatelet-richrelativelynewtechniqueAlthoughresultsatisfyinglevellowcomplicationratesdataeffectivenessremainsparseaimsevaluatepotentialtherapeuticeffectsMATERIALSANDMETHODS:prospectivelydesignedcomparingoutcomesn=15n=12differenttypesproducedpatients'peripheralbloodsamplesappliedeverywithoutapplyingtotalRESULTS:groupssimilaragesexcomorbiditiestime419010006increase108±80016ratestablethroughoutinitiallynegativebecame3rdCONCLUSION:applicationpromotesimprovesulcer'salthougheffectHoweverlargercomparativeseriesstillneededconfirmfindingsAutologousPlatelet-RichPlasmaNonhealingUlcers:ComparativeStudyPlatelet-richRegenerationUlcer

Similar Articles

Cited By